Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nadir R. Farid is active.

Publication


Featured researches published by Nadir R. Farid.


The New England Journal of Medicine | 1989

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.

Patrick S. Parfrey; Sheila M. Griffiths; Brendan J. Barrett; Michael D. Paul; Margot Genge; John Withers; Nadir R. Farid; Patrick J. McManamon

To determine the risk of nephrotoxicity induced by the infusion of radiographic contrast material, we undertook a prospective study of consecutive patients undergoing radiographic procedures with intravascular contrast material. There were three study groups: patients with diabetes mellitus and normal renal function (n = 85), patients with preexisting renal insufficiency (serum creatinine level, greater than or equal to 150 mumol per liter) without diabetes (n = 101), and patients with both diabetes and renal insufficiency (n = 34). The control group consisted of patients undergoing CT scanning or abdominal imaging procedures without the infusion of contrast material who had diabetes mellitus (n = 59), preexisting renal insufficiency (n = 145), or both (n = 64). Clinically important acute renal failure (defined as an increase of greater than 50 percent in the serum creatinine level) attributable to the contrast material did not occur in nondiabetic patients with preexisting renal insufficiency or in diabetics with normal renal function. The incidence of clinically important contrast-induced renal failure among the diabetic patients with preexisting renal insufficiency was 8.8 percent (95 percent confidence interval, 1.9 to 23.7 percent), as compared with 1.6 percent for the controls. The incidence of acute renal insufficiency, more broadly defined as an increase of greater than 25 percent in the serum creatinine level after the infusion of contrast material, was 11.8 percent among all patients with preexisting renal insufficiency. After the exclusion of patients whose acute renal insufficiency could be attributed to other causes, the incidence was 7.0 percent (95 percent confidence interval, 3.2 to 12.8 percent), as compared with 1.5 percent in the control group. The risk of acute renal insufficiency attributable to the contrast material was therefore 5.5 percent, and the relative risk associated with the infusion of contrast material was 4.7. These rates were similar whether the osmolarity of the contrast material was high or low. We conclude that there is little risk of clinically important nephrotoxicity attributable to contrast material for patients with diabetes and normal renal function or for nondiabetic patients with preexisting renal insufficiency. The risk for those with both diabetes and preexisting renal insufficiency is about 9 percent, which is lower than previously reported.


The New England Journal of Medicine | 1989

The Cardinal Manifestations of Bardet–Biedl Syndrome, a Form of Laurence–Moon–Biedl Syndrome

Jane Green; Patrick S. Parfrey; John D. Harnett; Nadir R. Farid; Benvon C. Cramer; Gordon J. Johnson; Olga Heath; Patrick J. McManamon; Elizabeth O'Leary; William Pryse-Phillips

To determine the interfamilial and intrafamilial variation in the expression of the Bardet-Biedl syndrome (a form of Laurence-Moon-Biedl syndrome), we looked for the five recognized features of the disorder (retinal dystrophy, obesity, polydactyly, mental retardation, and hypogonadism), plus possible renal manifestations, in some or all of 32 patients with this disorder. All 28 patients examined had severe retinal dystrophy, but only 2 had typical retinitis pigmentosa. Polydactyly was present in 18 of 31 patients, but syndactyly, brachydactyly, or both were present in all. Obesity was present in all but 1 of 25 patients. Only 13 of 32 patients were considered mentally retarded. Scores on verbal subtests of intelligence were usually lower than scores on performance tasks. Seven of eight men had small testes and genitalia, which was not due to hypogonadotropism. All 12 women studied had menstrual irregularities, and 3 had low serum estrogen levels (1 of these had hypogonadotropism, and 2 had primary gonadal failure). The remaining women who were of reproductive age had endocrinologic evidence of reproductive dysfunction. Diabetes mellitus was present in 9 of 20 patients. Renal structural or functional abnormalities were universal (n = 21), and three patients had end-stage renal failure. We conclude that the characteristic features of Bardet-Biedl syndrome are severe retinal dystrophy, dysmorphic extremities, obesity, renal abnormalities, and (in male patients only) hypogenitalism. Mental retardation, polydactyly, and hypogonadism in female patients are not necessarily present.


Diabetologia | 1982

Immunoglobulin Levels, Immunodeficiency and HLA in Type 1 (Insulin-Dependent) Diabetes Mellitus

S. Hoddinott; J. Dornan; J.C. Bear; Nadir R. Farid

SummaryIn 129 patients with Type 1 (insulin-dependent) diabetes mellitus, 100 healthy control subjects and 91 non-diabetic first degree relatives of Type 1 patients, we investigated variation in serum IgA, IgG and IgM concentrations with sex and HLA-B phenotype. Two patients with onset before the age of 15 years were completely IgA-deficient. One additional patient was completely IgG-deficient. Excluding these three cases, diabetic patients had serum IgA and IgM concentrations comparable to control subjects. IgG levels of patients were, however, significantly lower than those of control subjects (11.66 versus 12.69 g/l p = 0.003). Non-diabetic first degree relatives of patients had IgG levels intermediate between those of diabetic patients and control subjects. There was some indication that IgA concentrations were lower in the 53 patients with HLA-B8 (1.91 versus 2.21 g/l, p = 0.038). No association was found between IgM or IgG levels and HLA phenotypes.


Clinical Endocrinology | 1993

Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis

Yufei Shi; Minjing Zou; Nadir R. Farid

OBJECTIVE The clinical course of thyroid carcinoma is very variable. It is well known that thyroid carcinomas of similar histology can behave differently in terms of local invasion and distant metastases: there is no reliable way to predict the disease course with confidence. In the present study we compared the TSH receptor and c‐myc mRNA levels in different stages of thyroid carcinomas to identify whether they are useful markers for thyroid tumour biological behaviour and prognosis.


Immunology Letters | 1989

Cytotoxic endothelial cell antibodies in mixed connective tissue disease

Edith Bodolay; Ferenc Bojan; Gyula Szegedi; Valeria Stenszky; Nadir R. Farid

We examined the presence of anti-endothelial cell antibodies in the sera of 44 patients with mixed connective tissue disease (MCTD). Warm antibodies against endothelial cells were found in 45.4% of patients; the presence of these antibodies was positively correlated with anti-monocyte antibodies (P less than 0.01) but not with anti-lymphocytic antibodies. Strong correlations were found between the presence of these antibodies and abnormalities of pulmonary ventilatory capacity, neurophysiologic and myocardial function. Anti-endothelial antibodies were related to the high rate of spontaneous abortion noted in female MCTD patients. The identification of the antigen identified by MCTD sera in endothelial cells would help in understanding disease manifestations.


Archive | 1988

Anti-idiotypes, receptors, and molecular mimicry

D.S. Linthicum; Nadir R. Farid

This book provides a review of new methods and results in anti-idiotypes, receptors, and molecular mimicry. It begins with a discussion of the theoretical background of the anti-idiotypic network, its role in the regulation of immune response, and the physical characteristics of anti-idiotypic antibodies. It then goes on to explore many applications in such areas as insulin action, thyroid cell function, the neurosciences, cardiology, virology, pharmacology, and reproduction.


Human Heredity | 1985

Variant Multiple Endocrine Neoplasia I (MEN IBurin): Further Studies and Non-Linkage to HLA

John C. Bear; Rosario Briones-Urbina; James F. Fahey; Nadir R. Farid

We have extended our study of an incomplete variant of multiple endocrine neoplasia Type I (MEN IBurin). In this syndrome, primary hyperparathyroidism and prolactin-secreting adenoma are common, with hormone-secreting pancreatic tumors being rarely seen. The recent localization of the prolactin structural gene to chromosome 6 made further investigation of linkage to HLA of particular interest. Results in 2 multigeneration families exclude close linkage to HLA. We cannot at this time draw any inference regarding linkage of MEN IBurin to the prolactin structural gene.


Diabetes | 1980

Properdin Factor B(Bf) Allele BfF1 Specifies an HLA-B18 Diabetogenic Haplotype

John Dornan; Patricia Allan; Elke P. Noel; Bodil Larsen; Nadir R. Farid

We found the rare properdin factor B(Bf) variant F1 to be present in 11% of 72 patients suffering from insulindependent diabetes (IDDM) compared with 2% among 150 normal controls. BfF1 thus confers a relative risk for IDDM of 5.55. All eight patients and three controls who were BfF1 positive were also HLA-B18 positive, reflecting the strong linkage disequilibrium between these two factors. We suggest that BfF1 marks a ‘diabetogenic’ B18-bearing HLA haplotype. Studies of unselected families with one or more affected members suggest that the B18, BfF1 does not necessarily segregate with IDDM phenotype. This study provides further evidence for the genetic heterogeneity of IDDM.


Archive | 2009

Diagnosis and management of polycystic ovary syndrome

Nadir R. Farid; Evanthia Diamanti-Kandarakis

Diagnosis and management of polycystic ovary syndrome / , Diagnosis and management of polycystic ovary syndrome / , کتابخانه دیجیتال جندی شاپور اهواز


Archive | 1986

Bovine Thyrotropin Binding Sites in Nuclei and Nuclear Matrix of Porcine Thyrocytes

Nadir R. Farid

Thyrotropin (TSH) stimulates its thyroid target cells by interacting with specific receptors on the membrane (1). TSH binding sites have been purified and characterized in human and animal thyroid tissue using crude broken cell preparations, purified membranes, or whole cells (1,2). Our immunocytochemical studies, at light microscopical level, documented TSH binding sites intracellularly in porcine thyrocytes, particularly at the nuclear membrane and within the nucleus (2,3).

Collaboration


Dive into the Nadir R. Farid's collaboration.

Top Co-Authors

Avatar

John C. Bear

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar

Beverley S. Hawe

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar

John M. Barnard

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar

Rosario Briones-Urbina

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elke P. Noel

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar

Laura Sampson

Memorial University of Newfoundland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bodil Larsen

Memorial University of Newfoundland

View shared research outputs
Researchain Logo
Decentralizing Knowledge